Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
about
Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patientsContinuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.An overview on safety issues related to erythropoiesis-stimulating agents for the treatment of anaemia in patients with chronic kidney disease.Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.
P2860
Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Longer-term outcomes of darbep ...... asi-experimental cohort study.
@ast
Longer-term outcomes of darbep ...... asi-experimental cohort study.
@en
type
label
Longer-term outcomes of darbep ...... asi-experimental cohort study.
@ast
Longer-term outcomes of darbep ...... asi-experimental cohort study.
@en
prefLabel
Longer-term outcomes of darbep ...... asi-experimental cohort study.
@ast
Longer-term outcomes of darbep ...... asi-experimental cohort study.
@en
P2093
P2860
P1476
Longer-term outcomes of darbep ...... asi-experimental cohort study.
@en
P2093
Aya A Mitani
Benjamin A Goldstein
Emilee R Wilhelm-Leen
Glenn M Chertow
M Alan Brookhart
Tara I Chang
Victoria Ding
Wolfgang C Winkelmayer
P2860
P304
P356
10.1053/J.AJKD.2015.02.339
P577
2015-05-02T00:00:00Z